These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28336282)

  • 1. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
    Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
    J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type a for dysthyroid upper eyelid retraction.
    Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE
    Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction].
    Wabbels B; Förl M
    Ophthalmologe; 2007 Sep; 104(9):771-6. PubMed ID: 17823804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphometric analysis of eyelid fissure in patients with eyelid retraction in acute stage of dysthyroid orbitopathy after treatment with botulinum toxin type A].
    Costa PG; Saraiva FP; Pereira IC; Matayoshi S
    Arq Bras Oftalmol; 2008; 71(4):480-5. PubMed ID: 18797654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior rectus underaction following botulinum toxin injection to induce protective upper eye lid ptosis--a comparative study of two techniques.
    Sadiq SA; Dharmasena A
    Strabismus; 2014 Sep; 22(3):111-4. PubMed ID: 25005249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nylon Hang Back Sutures in the Repair of Secondary Ptosis Following Overcorrected Dysthyroid Upper Eyelid Retraction.
    Shah-Desai S; Azarbod P; Szamocki S; Rose GE
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):61-4. PubMed ID: 26505232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results.
    Ozturk Karabulut G; Fazil K; Saracoglu Yilmaz B; Ozturker C; Günaydın ZK; Taskapili M; Kaynak P
    Orbit; 2021 Oct; 40(5):381-388. PubMed ID: 32885692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease.
    Salour H; Bagheri B; Aletaha M; Babsharif B; Kleshadi M; Abrishami M; Bagheri A
    Orbit; 2010 Apr; 29(2):114-8. PubMed ID: 20394553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single transcutaneous injection with Botox for dysthyroid lid retraction.
    Shih MJ; Liao SL; Lu HY
    Eye (Lond); 2004 May; 18(5):466-9. PubMed ID: 15131675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal tear and raised intraocular pressure following unintentional intraocular botulinum toxin type A injection.
    Leung AK; Keyhani K; Ashenhurst M
    Can J Ophthalmol; 2007 Oct; 42(5):746-7. PubMed ID: 17724492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection.
    Uddin JM; Davies PD
    Ophthalmology; 2002 Jun; 109(6):1183-7. PubMed ID: 12045064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum Toxin Type A Injection for Correction of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
    Yang J; Hu X; Li Q; Huang RL
    J Craniofac Surg; 2023 Jul-Aug 01; 34(5):e485-e488. PubMed ID: 37221639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Afect of botulinum toxin-A injection on intraocular pressure and proptosis in thyroid associated orbitopathy.
    Lesin M; Bojić L; Romac R; Lesin J; Ivanisević M; Galetović D; Rogosić V
    Coll Antropol; 2009 Dec; 33(4):1155-7. PubMed ID: 20102062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: "Botulinum toxin type A for dysthyroid upper eyelid retraction".
    Fay A
    Ophthalmic Plast Reconstr Surg; 2005 Jan; 21(1):81; author reply 81-2. PubMed ID: 15677964
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study.
    Träisk F; Tallstedt L
    Acta Ophthalmol Scand; 2001 Dec; 79(6):585-8. PubMed ID: 11782224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
    Yücel OE; Artürk N
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of brow lifting using botulinum a toxin on upper eyelid height in patients with ptosis undergoing the frontal sling technique.
    Isik D; Tekin H; Karadag R; Bilgili SG; Atik B
    Ann Plast Surg; 2013 Feb; 70(2):175-9. PubMed ID: 22791060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease].
    Leray B; Imbert P; Thouvenin D; Boutault F; Caron P
    J Fr Ophtalmol; 2013 Dec; 36(10):874-85. PubMed ID: 24239215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injection for restrictive myopathy of thyroid-associated orbitopathy: success rate and predictive factors.
    Akbari MR; Ameri A; Keshtkar Jaafari AR; Mirmohammadsadeghi A
    J AAPOS; 2016 Apr; 20(2):126-130.e1. PubMed ID: 27079592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.